- Location
hepatitis B virus
"-
Diasorin Obtains Marketing Approvals for Hepatitis, Retroviral and Syphilis Assays
Feb 7, 2014DiaSorin, a biotechnology company, has received all the marketing approvals for hepatitis, retroviral and syphilis assays on its Liaison XL platform for the Chinese market. DiaSorin is now entering the hepatitis B, hepatitis C and ...
Tags: DiaSorin, HCV, HIV, pre-surgical screening testing
-
Monitoring Inactive Chronic Hepatitis B (Hbv) Carriers Is a Cost-Effective Strategy
Jan 16, 2014A novel study determined that monitoring inactive chronic hepatitis B (HBV) carriers is a cost-effective strategy for China. However, results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, ...
-
Advanced Biological Laboratories Has Acquired All The Assets of Evivar Medical
Jun 11, 2013Advanced Biological Laboratories (ABL) has acquired all the assets of Evivar Medical (Evivar), which includes its Hepatitis B virus (HBV) and C (HCV) web-based decision support tools and the associated viral genome analysis systems (SeqHepB ...
-
Spring Bank Pharmaceuticals Has Closed a $10.5m Series a Financing Round
Mar 5, 2013US-based biopharmaceutical company Spring Bank Pharmaceuticals has closed a $10.5m Series A financing round from Brock Securities with Gilford Securities as a participator. The firm is planning to invest the fund in its Phase I clinical ...
-
FDA Has Accepted Dynavax Technologies's Heplisav BLA for Immunization Against Infection
Dec 7, 2012The Food and Drug Administration (FDA) has accepted Dynavax Technologies' heplisav biologics license application (BLA) for immunization against infection caused by all known subtypes of hepatitis B virus in adults 18 through 70 years of ...
-
USPTO Grants a Notice of Allowance to Arrowhead's Formulation of DPC siRNA Delivery System
Nov 28, 2012The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Arrowhead Research's new formulation of dynamic polyconjugate (DPC) siRNA delivery system. The patent application No.13/032,029 covers claims for ...
Tags: siRNA delivery system, US Patent, dynamic polyconjugate, DPC platform
-
EMA Has Accepted to Review The Dynavax Technologies Marketing Authorization Application
Aug 23, 2012The European Medicines Agency (EMA) has accepted to review the Dynavax Technologies Marketing Authorization Application (MAA) for Heplisav. Heplisav is indicated for immunization against infection caused by all known subtypes of hepatitis ...
-
Dynavax Technologies Submitted a US Biologics License Application to the FDA for HEPLISAV
Apr 27, 2012Dynavax Technologies has submitted a US Biologics License Application (BLA) to the FDA for HEPLISAV, an investigational adult hepatitis B vaccine. In Phase III trials, HEPLISAV demonstrated higher and earlier protection with fewer ...
Related Products
-
Singclean Wholesale CE Approved Ivd Human Serum and Plasma HBV Hepatitis B Hbsag Rapid Virus Medical Test Kit Surface Antigen (Colloidal Gold) for HBV Infection
-
GMP Supply Tenofovir Alafenamide Fumarate CAS No. 1392275-56-7 Anti-Hepatitis B Virus
-
High Quality Testsealabs HBsAb Hepatitis B Virus E Antibody Test Cassette Rapid Test Kit with ISO
-
Hot Sale! ! ! Testsealabs OEM Hbsag Hepatitis B Virus Core Antibody Diagnostic Cassette HBsAb-Core Rapit Test Kit with ISO
-
Ivd Test HCG HIV Std Influenza 19 Virus H. Pylori Syphilis Dengue Hbsag Hepatitis B Pregnancy Malaria Elisa Urs10 Hpv Glucose Strips Cassette Rapid Test Kit
-
Self Test HCG HIV Hbasag Influenza 19 Virus H.Pylori Syphilis Dengue Hepatitis B Pregnancy Malaria Elisa Urine 10 Urs Hpv Glucose Strips Cassette Rapid Test Kit
